Clinical Trial Update: Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adjuvant treatment for incomplete resection thymoma or thymic carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma
• Thymoma

Snippet

Sponsor: Fudan University | Conditions: Thymoma and Thymic Carcinoma | Phase 3 | Status: WITHDRAWN